N6', N6''', and O4' Modifications to Neomycin Affect Ribosomal Selectivity without Compromising Antibacterial Activity.
N6', N6''', and O4' Modifications to Neomycin Affect Ribosomal Selectivity without Compromising Antibacterial Activity.
复制标题
新霉素的 N6、N6 和 O4 修饰会影响核糖体选择性,但不会影响抗菌活性。
DOI:
10.1021/acsinfecdis.6b00214
复制
发表时间:
2017
影响因子:
5.3
通讯作者:
Crich,David
中科院分区:
文献类型:
--
作者:
Sati,GirishC;Shcherbakov,Dimitri;Hobbie,SvenN;Vasella,Andrea;Böttger,ErikC;Crich,David
The synthesis of a series of neomycin derivatives carrying the 2-hydroxyethyl substituent on N6′ and/or N6‴ both alone and in combination with a 4′-O-ethyl group is described. By means of cell-free translation assays with wild-type bacterial ribosomes and their hybrids with eukaryotic decoding A sites, we investigate how individual substituents and their combinations affect activity and selectivity at the target level. In principle, and as shown by cell-free translation assays, modifications of the N6′ and N6‴ positions allow enhancement of target selectivity without compromising antibacterial activity. As with the 6′OH aminoglycoside paromomycin, the 4′-O-ethyl modification affects the ribosomal activity, selectivity, and antibacterial profile of neomycin and its 6′-N-(2-hydroxyethyl) derivatives. The modified aminoglycosides show good antibacterial activity against model Gram-positive and Gram-negative microbes including the ESKAPE pathogensStaphylococcus aureus,Klebsiella pneumoniae,Enterobacter cloacae, andAcinetobacter baumannii.